Viveve Medical, Inc. (VIVE): Price and Financial Metrics
VIVE Stock Summary
- VIVE has a market capitalization of $29,370,473 -- more than approximately merely 6.44% of US stocks.
- In terms of volatility of its share price, VIVE is more volatile than 97.67% of stocks we're observing.
- Viveve Medical Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -34.36%, greater than the shareholder yield of only 7.61% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Viveve Medical Inc, a group of peers worth examining would be YELP, MGNI, TENB, ASPN, and DOMO.
- VIVE's SEC filings can be seen here. And to visit Viveve Medical Inc's official web site, go to www.viveve.com.
VIVE Stock Price Chart Interactive Chart >
VIVE Price/Volume Stats
|Current price||$2.98||52-week high||$14.40|
|Prev. close||$2.84||52-week low||$2.43|
|Day high||$2.98||Avg. volume||1,866,924|
|50-day MA||$3.34||Dividend yield||N/A|
|200-day MA||$4.68||Market Cap||30.82M|
Viveve Medical, Inc. (VIVE) Company Bio
Viveve Medical, Inc. designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal laxity. The company was founded in 2005 and is based in Sunnyvale, California.
VIVE Latest News Stream
|Loading, please wait...|
VIVE Latest Social Stream
View Full VIVE Social Stream
Latest VIVE News From Around the Web
Below are the latest news stories about Viveve Medical Inc that investors may wish to consider to help them evaluate VIVE as an investment opportunity.
Company continuing to advance its U.S. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET today ENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today reported financial results for the year ended… Read More »Viveve Reports Full Year 2020 Financial Results and Provides Corporate Update
Company continuing to advance its U. pivotal PURSUIT trial in stress urinary incontinence Conference call to be hosted by Company at 5:00 PM ET todayENGLEWOOD, CO / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc.
NEW YORK, NY / ACCESSWIRE / March 18, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 18, 2021 at 5:00 PM Eastern Time.
The Daily Biotech Pulse: Fulgent's Big Quarter, Gilead Awaits FDA Decision, Apellis Winds Up COVID-19 Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) AtriCure, Inc. (NASDAQ: ATRC ) Five Prime Therapeutics, Inc. ( NASDAQ: FPRX) - announced a deal to be bought by Amgen Inc. (NASDAQ: AMGN ) for $1.9 billion Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 4) AbCellera Biologics Inc. (NASDAQ: ABCL ) Acutus Medical, Inc. (NASDAQ: AFIB ) ADC Therapeutics SA (NYSE: ADCT ) Aptose Biosciences Inc. (NASDAQ: APTO ) Assembly Biosciences, Inc. (NASDAQ: ASMB ) Athenex, Inc. (NASDAQ: ATNX ) Biophytis SA (NASDAQ: BPTS ) Bioventus Inc. (NASDAQ: BVS ) Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI ) BriaCell Therapeutics Corp. (NASDAQ: BCTX ) Decibel Therapeutics, Inc. (NASDAQ: DBTX ) Dyne Ther...
ENGLEWOOD, CO / ACCESSWIRE / March 2, 2021 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer, will participate in the virtual H.
VIVE Price Returns